TSMRF(TSMRF)
TSMRF
No analyst ratings available
No analyst price targets available for TSMRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $215.68B | $227.93B | $238.17B | $245.63B | $268.67B |
| Low | $213.86B | $224.68B | $235.44B | $242.82B | $265.60B |
| High | $218.21B | $231.84B | $241.62B | $249.20B | $272.57B |
| EBITDA Avg | $55.35B | $58.50B | $61.13B | $63.04B | $68.95B |
| Low | $54.89B | $57.66B | $60.43B | $62.32B | $68.17B |
| High | $56.00B | $59.50B | $62.01B | $63.96B | $69.96B |
| EBIT Avg | $40.37B | $42.66B | $44.57B | $45.97B | $50.28B |
| Low | $40.03B | $42.05B | $44.06B | $45.44B | $49.71B |
| High | $40.84B | $43.39B | $45.22B | $46.64B | $51.01B |
| Net Income Avg | $25.67B | $26.57B | $27.34B | $17.75B | $34.62B |
| Low | $25.28B | $26.17B | $26.94B | $17.49B | $34.10B |
| High | $26.15B | $27.07B | $27.86B | $18.09B | $35.27B |
| EPS Avg | $343.47 | $355.57 | $365.90 | $237.58 | $463.26 |
| Low | $338.37 | $350.29 | $360.46 | $234.05 | $456.37 |
| High | $349.96 | $362.28 | $372.81 | $242.06 | $472.00 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $53.62B | $55.94B | $51.27B |
| Low | $52.07B | $54.32B | $49.79B |
| High | $55.17B | $57.56B | $52.75B |
| EBITDA Avg | $13.76B | $14.36B | $13.16B |
| Low | $13.36B | $13.94B | $12.78B |
| High | $14.16B | $14.77B | $13.54B |
| EBIT Avg | $10.04B | $10.47B | $9.60B |
| Low | $9.74B | $10.17B | $9.32B |
| High | $10.33B | $10.77B | $9.87B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 1 / — | 1 / — |